EPISODE · Jul 18, 2022 · 9 MIN
Mavenclad Efficacy, Safety Similar to Trials & Staying Cool in the Summer Heat
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge explains how the safety and efficacy of Mavenclad in a real-world group of RRMS patients, were similar to what was observed in its clinical trials.He also reads “A New Gift Helps Me Stay Cool in the Summer Heat”, by Ed Tobias from his column “The MS Wire.”=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
Embed this episode
NOW PLAYING
Mavenclad Efficacy, Safety Similar to Trials & Staying Cool in the Summer Heat
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.